- Home
- BLMN vs ARVN Comparison
BLMN vs ARVN Comparison
Compare BLMN & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- ARVN
- Stock Information
- Founded
- BLMN 1988
- ARVN 2015
- Country
- BLMN United States
- ARVN United States
- Employees
- BLMN 81000
- ARVN N/A
- Industry
- BLMN Restaurants
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- BLMN Consumer Discretionary
- ARVN Health Care
- Exchange
- BLMN Nasdaq
- ARVN Nasdaq
- Market Cap
- BLMN 738.9M
- ARVN 1.2B
- IPO Year
- BLMN 2012
- ARVN 2018
- Fundamental
- Price
- BLMN $8.70
- ARVN $8.30
- Analyst Decision
- BLMN Hold
- ARVN Strong Buy
- Analyst Count
- BLMN 11
- ARVN 12
- Target Price
- BLMN $14.60
- ARVN $54.91
- AVG Volume (30 Days)
- BLMN 3.0M
- ARVN 2.0M
- Earning Date
- BLMN 05-06-2025
- ARVN 05-06-2025
- Dividend Yield
- BLMN 9.95%
- ARVN N/A
- EPS Growth
- BLMN N/A
- ARVN N/A
- EPS
- BLMN N/A
- ARVN N/A
- Revenue
- BLMN $3,950,475,000.00
- ARVN $263,399,999.00
- Revenue This Year
- BLMN $1.03
- ARVN N/A
- Revenue Next Year
- BLMN $1.75
- ARVN $7.99
- P/E Ratio
- BLMN N/A
- ARVN N/A
- Revenue Growth
- BLMN N/A
- ARVN 235.54
- 52 Week Low
- BLMN $8.00
- ARVN $7.91
- 52 Week High
- BLMN $29.31
- ARVN $46.62
- Technical
- Relative Strength Index (RSI)
- BLMN 33.74
- ARVN 21.43
- Support Level
- BLMN $8.00
- ARVN $15.53
- Resistance Level
- BLMN $9.51
- ARVN $18.93
- Average True Range (ATR)
- BLMN 0.70
- ARVN 1.50
- MACD
- BLMN -0.15
- ARVN -0.50
- Stochastic Oscillator
- BLMN 15.66
- ARVN 3.44
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.